Bioassays for Screening Antituberculosis Drugs Platform

Fiocruz’s Network Technological Platforms.

The Bioassays for screening anti-tuberculosis drugs platform performs microbiological tests to detect activity of natural and synthetic compounds against the M. tuberculosis complex, non-tuberculosis mycobacteria and others bacterias, using the broth microdilution method with oxidation indicator (MTT), colony count (UFC), BACTEC MGIT 960 and early bactericidal activity. This platform also perform tests with resistent strains. In addition, cytotoxicity assays using the MTT method and bactericidal activity in macrophage are offered when a compound shows activity against the mycobacteria tested.

This platform is located in FIOCRUZ – Rio de Janeiro (INI).

Head of Platform: Maria Cristina da Silva Lourenco;
Technical Manager: Leonardo Bruno Paz Ferreira Barreto

Americas

FIOCRUZ

Category: Medium-High Throughput, Low or High Content Screening
Head: Maria Critina da Silva Lourenço - Head
Contact: cristina.lourenco@ini.fiocruz.br / plataformas@fiocruz.br
Language: English/Portuguese
Access procedure: Please contact the platform team
Price: leonardo.barreto@ini.fiocruz.br
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.